Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer

被引:57
|
作者
Pinaquy, Jean-Baptiste [1 ]
De Clermont-Galleran, Henri [1 ,2 ]
Pasticier, Gilles [3 ]
Rigou, Gerald [4 ]
Alberti, Nicolas [4 ]
Hindie, Elif [1 ,2 ]
Mokrane, Yacoub [5 ]
Fernandez, Philippe [1 ,2 ]
机构
[1] Hop Pellegrin, Dept Nucl Med, F-33076 Bordeaux, France
[2] Univ Bordeaux, INCIA, UMR CNRS 5287, Bordeaux, France
[3] Hop Pellegrin, Dept Urol, F-33076 Bordeaux, France
[4] Hop Pellegrin, Dept Radiol, F-33076 Bordeaux, France
[5] Hop Pellegrin, Dept Pathol, F-33076 Bordeaux, France
来源
PROSTATE | 2015年 / 75卷 / 03期
关键词
F-18]-fluorocholine; DWI; MRI; prostate cancer; staging; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LYMPH-NODES; RADICAL PROSTATECTOMY; LOCALIZATION; INTERMEDIATE; NOMOGRAM; DISEASE;
D O I
10.1002/pros.22921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Accurate staging is important before surgical decision in patients with high-risk prostate cancer (PCa). The purpose of this study was to prospectively compare the diagnostic performance of F-18-FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND). METHODS. We identified 47 patients who underwent F-18-FCholine and DWIMRI followed by surgical treatment (either prostatectomy or LN dissection or an association of prostatectomy and LN dissection) between May 2010 and December 2012 at Bordeaux University Hospital. These patients were part of a prospective study (EudraCT number 2009-014839-21) evaluating the interest of F-18-FCholine in staging of high-risk PCa. Diagnostic performances were retrospectively determined for each of F-18-FCholine and DWIMRI considering LN invasion, each of prostate sextants, capsular invasion and extension to seminal vesicles. F-18-FCholine and MR findings were correlated with histological findings. RESULTS. In a region-based LN analysis, the sensitivity and positive predictive value specificity were respectively, 56% and 98% for F-18-Choline, and 17% and 97% for DWIMRI. In a patient-based analysis the sensitivity and positive predictive value were respectively 78% and 94% for F-18-Choline and 33% and 84% for DWIMRI (P = 0.015). For tumor staging, DWIMRI showed better performances with a better specificity (69%) for sextants analysis and sensitivity to detect seminal vesicle invasion (73% vs. 36%). CONCLUSIONS. F-18-FCholine imaging appears to provide helpful additional information in the staging of high-risk PCa. It appears essential for predicting LN status due to its higher sensitivity and specificity for LN involvement. However, despite excellent performance, it cannot replace MRI that remains better for tumoral localization and local evaluation, especially for seminal vesicle invasion. PATIENT SUMMARY. This study highlights the interest of F-18-Choline in the staging of high risk prostate cancer in addition with DWI MRI, especially so in the evaluation of lymph node involvement due to its high sensitivity and excellent specificity. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [31] Whole-Body Diffusion-Weighted MRI Compared With 18F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma
    Mosavi, Firas
    Johansson, Silvia
    Sandberg, Dan T.
    Turesson, Ingela
    Sorensen, Jens
    Ahlstrom, Hakan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (05) : 1114 - 1120
  • [32] 18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer
    Lord, Martin
    Ratib, Osman
    Vallee, Jean-Paul
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) : 2288 - 2288
  • [33] 18F-Fluorocholine integrated PET/MRI for the initial staging of prostate cancer
    Martin Lord
    Osman Ratib
    Jean-Paul Vallée
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 2288 - 2288
  • [34] F-18-Fluorocholine PET/MRI as a prostate cancer staging and restaging modality: Comparison study with F-18-FDG PET/MRI and PET/CT
    Kim, Yong-il
    Paeng, Jin Chul
    Kang, Keon Wook
    Lee, Dong Soo
    Chung, June-Key
    Cho, Jeong Yeon
    Kwak, Cheol
    Kim, E. Edmund
    Cheon, Gi Jeong
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [35] Can [18F]DCFPyL PET/CT replace [18F]Fluorocholine PET/CT in all the diagnostic settings of prostate cancer
    Ortiz, S. Guzman
    Navas, M. Meneses
    Montijano, M. Cruz
    Zoghby, L. Garcia
    Plaza, J. Bonilla
    Garcia, V. Poblete
    Vicente, A. Garcia
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S550 - S551
  • [36] Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study
    Mathieu Gauthé
    Cyrielle Aveline
    Frédéric Lecouvet
    Laure Michaud
    Caroline Rousseau
    Marc Tassart
    Olivier Cussenot
    Jean-Noël Talbot
    Isabelle Durand-Zaleski
    World Journal of Urology, 2019, 37 : 1587 - 1595
  • [37] Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study
    Gauthe, Mathieu
    Aveline, Cyrielle
    Lecouvet, Frederic
    Michaud, Laure
    Rousseau, Caroline
    Tassart, Marc
    Cussenot, Olivier
    Talbot, Jean-Noel
    Durand-Zaleski, Isabelle
    WORLD JOURNAL OF UROLOGY, 2019, 37 (08) : 1587 - 1595
  • [38] Staging primary prostate cancer with 68Ga-PSMAHBED-CC/[18F]Fluorocholine-PET/MRI
    Hartenbach, M.
    Baltzer, P.
    Hartenbach, S.
    Susani, M.
    Seitz, C.
    Kenner, L.
    Kramer, G.
    Haug, A. R.
    Wadsak, W.
    Mitterhauser, M.
    Ponholzer, A.
    Lamche, M.
    Shariat, S.
    Hacker, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S165 - S165
  • [39] Simultaneous 18F-FACBC PET/MRI for staging of high-risk prostate cancer.
    Elschot, Mattijs
    Selnaes, Kirsten
    Kruger-Stokke, Brage
    Storkersen, Oystein
    Tessem, May-Britt
    Willoch, Frode
    Bertilsson, Helena
    Moestue, Siver
    Bathen, Tone
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [40] Imaging of prostate cancer with PET/CT using F-18-Fluorocholine
    Vali, Reza
    Loidl, Wolfgang
    Pirich, Christian
    Langesteger, Werner
    Beheshti, Mohsen
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 5 (02): : 96 - 108